6RTM
Thioredoxin glutathione reductase from Schistosoma mansoni in complex with 1-[(dimethylamino)methyl]-2-naphthol at 2 hour of soaking
6RTM の概要
| エントリーDOI | 10.2210/pdb6rtm/pdb |
| 分子名称 | Thioredoxin glutathione reductase, FLAVIN-ADENINE DINUCLEOTIDE, TRIETHYLENE GLYCOL, ... (6 entities in total) |
| 機能のキーワード | fragment, secondary site, schistosomiasis, fad/nad linked reductase, flavoprotein, time-resolved structural studies |
| 由来する生物種 | Schistosoma mansoni |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 66389.22 |
| 構造登録者 | Angelucci, F.,Silvestri, I.,Fata, F.,Williams, D.L. (登録日: 2019-05-24, 公開日: 2020-01-08, 最終更新日: 2024-10-16) |
| 主引用文献 | Silvestri, I.,Lyu, H.,Fata, F.,Banta, P.R.,Mattei, B.,Ippoliti, R.,Bellelli, A.,Pitari, G.,Ardini, M.,Petukhova, V.,Thatcher, G.R.J.,Petukhov, P.A.,Williams, D.L.,Angelucci, F. Ectopic suicide inhibition of thioredoxin glutathione reductase. Free Radic Biol Med, 147:200-211, 2020 Cited by PubMed Abstract: Selective suicide inhibitors represent a seductively attractive approach for inactivation of therapeutically relevant enzymes since they are generally devoid of off-target toxicity in vivo. While most suicide inhibitors are converted to reactive species at enzyme active sites, theoretically bioactivation can also occur in ectopic (secondary) sites that have no known function. Here, we report an example of such an "ectopic suicide inhibition", an unprecedented bioactivation mechanism of a suicide inhibitor carried out by a non-catalytic site of thioredoxin glutathione reductase (TGR). TGR is a promising drug target to treat schistosomiasis, a devastating human parasitic disease. Utilizing hits selected from a high throughput screening campaign, time-resolved X-ray crystallography, molecular dynamics, mass spectrometry, molecular modeling, protein mutagenesis and functional studies, we find that 2-naphtholmethylamino derivatives bound to this novel ectopic site of Schistosoma mansoni (Sm)TGR are transformed to covalent modifiers and react with its mobile selenocysteine-containing C-terminal arm. In particular, one 2-naphtholmethylamino compound is able to specifically induce the pro-oxidant activity in the inhibited enzyme. Since some 2-naphtholmethylamino analogues show worm killing activity and the ectopic site is not conserved in human orthologues, a general approach to development of novel and selective anti-parasitic therapeutics against schistosoma is proposed. PubMed: 31870799DOI: 10.1016/j.freeradbiomed.2019.12.019 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.1 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






